277 Safety and efficacy of intratumoral ipilimumab with IV nivolumab in metastatic melanoma. The NIVIPIT trial

• Jean-Yves Scoazec,
• Francois-Xavier Danlos,
• Caroline Robert,
• Aurélien Marabelle,
• Celeste Lebbe,
• Laurence Zitvogel,
• Stephane Dalle,
• Samy Ammari,
• Lambros Tselikas,
• Nicolas Meyer,
• Severine Roy,
• Camille Jannin,
• Siham Farhane,
• Severine Mourad,
• Guillaume Escriou,
• Thibault Raoult,
• Matthieuu Texier,
• Nathalie Chaput-Gras,
• Thierry De Baere

Affiliations

Jean-Yves Scoazec

Department of Pathology, Edouard Herriot hospital, University of Lyon , Lyon, France

Francois-Xavier Danlos

1 Medical Oncology and Drug Development Department, Institut Gustave Roussy, Villejuif, France

Caroline Robert

Gustave Roussy and Paris-Saclay University, Villejuif, France

Aurélien Marabelle

17 Drug Development, Gustave Roussy Cancer Center, Villejuif, France

Celeste Lebbe

AP-HP Dermatology and CIC, INSERM U976, Saint Louis Hospital, Université de Paris, Paris, France

Laurence Zitvogel

Aff21 grid.14925.3b0000000122849388Institute Gustave Roussy Villejuif France

Stephane Dalle

8 Hospices Civils de Lyon, Pierre Bénite, France

Samy Ammari

Aff3 0000 0001 2284 9388grid.14925.3bDepartment of RadiologyGustave Roussy Cancer Campus 94800 Villejuif France

Lambros Tselikas

1 Interventional Radiology, Gustave Roussy, Villejuif, France

Nicolas Meyer

Public Health, Methods in Clinical Research Team, Hopitaux universitaires de Strasbourg, Strasbourg, Alsace, France

Severine Roy

Gustave Roussy and Paris-Saclay University, Villejuif, France

Camille Jannin

1Gustave Roussy, Villejuif, France

Siham Farhane

1Gustave Roussy, Villejuif, France

Severine Mourad

1Gustave Roussy, Villejuif, France

Guillaume Escriou

1Gustave Roussy, Villejuif, France

Thibault Raoult

1Gustave Roussy, Villejuif, France

Matthieuu Texier

1Gustave Roussy, Villejuif, France

Nathalie Chaput-Gras

1Gustave Roussy, Villejuif, France

Thierry De Baere

1Gustave Roussy, Villejuif, France